25 XP   0   0   10

Gufic Biosciences Limited
Buy, Hold or Sell?

Let's analyze Gufic together

I guess you are interested in Gufic Biosciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gufic Biosciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.

Quick analysis of Gufic (30 sec.)










What can you expect buying and holding a share of Gufic? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR27.76
Expected worth in 1 year
INR67.24
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR39.86
Return On Investment
11.0%

For what price can you sell your share?

Current Price per Share
INR362.65
Expected price per share
INR294.85 - INR387.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Gufic (5 min.)




Live pricePrice per Share (EOD)

INR362.65

Intrinsic Value Per Share

INR33.29 - INR73.19

Total Value Per Share

INR61.05 - INR100.95

2. Growth of Gufic (5 min.)




Is Gufic growing?

Current yearPrevious yearGrowGrow %
How rich?$32.2m$20.8m$11.4m35.6%

How much money is Gufic making?

Current yearPrevious yearGrowGrow %
Making money$11.5m$5.3m$6.1m53.8%
Net Profit Margin12.3%9.1%--

How much money comes from the company's main activities?

3. Financial Health of Gufic (5 min.)




4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Gufic? (5 min.)

Welcome investor! Gufic's management wants to use your money to grow the business. In return you get a share of Gufic.

What can you expect buying and holding a share of Gufic?

First you should know what it really means to hold a share of Gufic. And how you can make/lose money.

Speculation

The Price per Share of Gufic is INR362.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gufic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gufic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR27.76. Based on the TTM, the Book Value Change Per Share is INR9.87 per quarter. Based on the YOY, the Book Value Change Per Share is INR8.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gufic.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.120.0%0.120.0%0.050.0%0.050.0%0.030.0%
Usd Book Value Change Per Share0.120.0%0.120.0%0.100.0%0.060.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.120.0%0.120.0%0.100.0%0.060.0%0.040.0%
Usd Price Per Share2.99-2.99-1.37-1.43-0.96-
Price to Earnings Ratio25.18-25.18-25.05-29.67-31.52-
Price-to-Total Gains Ratio24.98-24.98-14.22-59.85-66.16-
Price to Book Ratio8.97-8.97-6.39-8.71-8.22-
Price-to-Total Gains Ratio24.98-24.98-14.22-59.85-66.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.3518
Number of shares229
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.120.06
Usd Total Gains Per Share0.120.06
Gains per Quarter (229 shares)27.3812.78
Gains per Year (229 shares)109.5351.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1110810015041
22217210110192
333253202151143
444344302202194
555425403252245
666516504303296
777597604353347
888688705404398
999769806454449
1010108510906505500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Gufic

About Gufic Biosciences Limited

Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anaesthetics, and immuno suppressants, as well as intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-06-23 12:34:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Gufic Biosciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Gufic earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • A Net Profit Margin of 12.3%¬†means that¬†₹0.12 for each ₹1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gufic Biosciences Limited:

  • The MRQ is 12.3%. The company is making a huge profit. +2
  • The TTM is 12.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.3%TTM12.3%0.0%
TTM12.3%YOY9.1%+3.2%
TTM12.3%5Y7.9%+4.4%
5Y7.9%10Y5.8%+2.0%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3%8.5%+3.8%
TTM12.3%8.5%+3.8%
YOY9.1%9.1%0.0%
5Y7.9%5.6%+2.3%
10Y5.8%5.8%+0.0%
1.1.2. Return on Assets

Shows how efficient Gufic is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • 18.4% Return on Assets means that¬†Gufic generated¬†₹0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gufic Biosciences Limited:

  • The MRQ is 18.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 18.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.4%TTM18.4%0.0%
TTM18.4%YOY11.3%+7.1%
TTM18.4%5Y10.2%+8.2%
5Y10.2%10Y7.5%+2.6%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ18.4%8.6%+9.8%
TTM18.4%8.6%+9.8%
YOY11.3%10.4%+0.9%
5Y10.2%5.5%+4.7%
10Y7.5%6.4%+1.1%
1.1.3. Return on Equity

Shows how efficient Gufic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • 35.6% Return on Equity means Gufic generated ₹0.36¬†for each¬†₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gufic Biosciences Limited:

  • The MRQ is 35.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 35.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ35.6%TTM35.6%0.0%
TTM35.6%YOY25.5%+10.1%
TTM35.6%5Y28.9%+6.7%
5Y28.9%10Y25.1%+3.8%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ35.6%13.8%+21.8%
TTM35.6%13.8%+21.8%
YOY25.5%17.1%+8.4%
5Y28.9%9.2%+19.7%
10Y25.1%11.4%+13.7%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Gufic Biosciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gufic is operating .

  • Measures how much profit Gufic makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • An Operating Margin of 0.0%¬†means the company generated ₹0.00 ¬†for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gufic Biosciences Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.4%-8.4%
5Y8.4%10Y8.2%+0.2%
1.2.2. Operating Ratio

Measures how efficient Gufic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Drugs - Generic industry mean).
  • An Operation Ratio of 0.57 means that the operating costs are ₹0.57 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.567. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.567. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.5670.000
TTM0.567YOY0.558+0.009
TTM0.5675Y1.087-0.520
5Y1.08710Y1.256-0.168
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5670.5670.000
TTM0.5670.5670.000
YOY0.5580.558+0.000
5Y1.0871.087+0.000
10Y1.2561.2560.000
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Gufic Biosciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gufic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Drugs - Generic industry mean).
  • A Current Ratio of 1.72¬†means the company has ₹1.72 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.715. The company is able to pay all its short-term debts. +1
  • The TTM is 1.715. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.715TTM1.7150.000
TTM1.715YOY1.592+0.123
TTM1.7155Y1.381+0.335
5Y1.38110Y1.260+0.120
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7151.715+0.000
TTM1.7151.715+0.000
YOY1.5921.592+0.000
5Y1.3811.3810.000
10Y1.2601.260+0.000
1.3.2. Quick Ratio

Measures if Gufic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • A Quick Ratio of 1.03¬†means the company can pay off ₹1.03 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 1.032. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.032. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.032TTM1.0320.000
TTM1.032YOY0.883+0.148
TTM1.0325Y0.726+0.306
5Y0.72610Y0.651+0.074
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0320.859+0.173
TTM1.0320.859+0.173
YOY0.8830.739+0.144
5Y0.7260.644+0.082
10Y0.6510.651+0.000
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Gufic Biosciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gufic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Gufic to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.48¬†means that Gufic assets are¬†financed with 48.4% credit (debt) and the remaining percentage (100% - 48.4%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.484. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.484. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.484TTM0.4840.000
TTM0.484YOY0.558-0.074
TTM0.4845Y0.655-0.171
5Y0.65510Y0.714-0.059
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4840.4840.000
TTM0.4840.4840.000
YOY0.5580.542+0.016
5Y0.6550.544+0.111
10Y0.7140.607+0.107
1.4.2. Debt to Equity Ratio

Measures if Gufic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • A Debt to Equity ratio of 93.7% means that company has ₹0.94 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gufic Biosciences Limited:

  • The MRQ is 0.937. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.937. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.937TTM0.9370.000
TTM0.937YOY1.261-0.323
TTM0.9375Y2.204-1.267
5Y2.20410Y2.890-0.686
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9370.937+0.000
TTM0.9370.937+0.000
YOY1.2611.181+0.080
5Y2.2041.199+1.005
10Y2.8901.918+0.972
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Gufic Biosciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every ₹1 in earnings Gufic generates.

  • Above 15 is considered overpriced but¬†always compare¬†Gufic to the¬†Drugs - Generic industry mean.
  • A PE ratio of 25.18 means the investor is paying ₹25.18¬†for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gufic Biosciences Limited:

  • The EOD is 36.683. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.177. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.177. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.683MRQ25.177+11.506
MRQ25.177TTM25.1770.000
TTM25.177YOY25.052+0.125
TTM25.1775Y29.668-4.491
5Y29.66810Y31.520-1.852
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD36.68336.278+0.405
MRQ25.17725.1770.000
TTM25.17725.1770.000
YOY25.05222.416+2.636
5Y29.66826.162+3.506
10Y31.52018.338+13.182
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gufic Biosciences Limited:

  • The EOD is 187.139. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 128.441. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 128.441. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD187.139MRQ128.441+58.699
MRQ128.441TTM128.4410.000
TTM128.441YOY14.804+113.637
TTM128.4415Y17.113+111.327
5Y17.11310Y-2.340+19.454
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD187.13915.352+171.787
MRQ128.44113.341+115.100
TTM128.44113.341+115.100
YOY14.80414.8040.000
5Y17.11317.113+0.000
10Y-2.3404.165-6.505
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gufic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Drugs - Generic industry mean).
  • A PB ratio of 8.97 means the investor is paying ₹8.97¬†for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Gufic Biosciences Limited:

  • The EOD is 13.064. Based on the equity, the company is expensive. -2
  • The MRQ is 8.966. Based on the equity, the company is overpriced. -1
  • The TTM is 8.966. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.064MRQ8.966+4.098
MRQ8.966TTM8.9660.000
TTM8.966YOY6.389+2.577
TTM8.9665Y8.708+0.258
5Y8.70810Y8.216+0.492
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD13.0642.969+10.095
MRQ8.9662.918+6.048
TTM8.9662.918+6.048
YOY6.3893.836+2.553
5Y8.7083.175+5.533
10Y8.2163.619+4.597
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Gufic Biosciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--9.8709.8700%8.003+23%4.593+115%3.084+220%
Book Value Per Share--27.76027.7600%17.890+55%14.435+92%9.724+185%
Current Ratio--1.7151.7150%1.592+8%1.381+24%1.260+36%
Debt To Asset Ratio--0.4840.4840%0.558-13%0.655-26%0.714-32%
Debt To Equity Ratio--0.9370.9370%1.261-26%2.204-57%2.890-68%
Dividend Per Share--0.0950.0950%0.037+154%0.056+68%0.053+78%
Eps--9.8869.8860%4.563+117%4.348+127%2.769+257%
Free Cash Flow Per Share--1.9381.9380%7.721-75%1.509+28%0.867+124%
Free Cash Flow To Equity Per Share--1.2941.2940%-0.389+130%0.270+379%0.182+609%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--73.190--------
Intrinsic Value_10Y_min--33.293--------
Intrinsic Value_1Y_max--4.267--------
Intrinsic Value_1Y_min--1.990--------
Intrinsic Value_3Y_max--15.157--------
Intrinsic Value_3Y_min--7.180--------
Intrinsic Value_5Y_max--28.867--------
Intrinsic Value_5Y_min--13.647--------
Market Cap28225049500.000+15%24129488539.00024129488539.0000%11080757493.000+118%10825049735.700+123%7106217330.944+240%
Net Profit Margin--0.1230.1230%0.091+36%0.079+56%0.058+110%
Operating Margin----0%-0%0.084-100%0.082-100%
Operating Ratio--0.5670.5670%0.558+2%1.087-48%1.256-55%
Pb Ratio13.064+31%8.9668.9660%6.389+40%8.708+3%8.216+9%
Pe Ratio36.683+31%25.17725.1770%25.052+0%29.668-15%31.520-20%
Price Per Share362.650+31%248.900248.9000%114.300+118%118.930+109%80.107+211%
Price To Free Cash Flow Ratio187.139+31%128.441128.4410%14.804+768%17.113+651%-2.340+102%
Price To Total Gains Ratio36.393+31%24.97824.9780%14.216+76%59.854-58%66.159-62%
Quick Ratio--1.0321.0320%0.883+17%0.726+42%0.651+58%
Return On Assets--0.1840.1840%0.113+63%0.102+81%0.075+144%
Return On Equity--0.3560.3560%0.255+40%0.289+23%0.251+42%
Total Gains Per Share--9.9659.9650%8.040+24%4.649+114%3.138+218%
Usd Book Value--32294160.00032294160.0000%20812380.000+55%16029408.000+101%10497361.333+208%
Usd Book Value Change Per Share--0.1180.1180%0.096+23%0.055+115%0.037+220%
Usd Book Value Per Share--0.3330.3330%0.215+55%0.173+92%0.117+185%
Usd Dividend Per Share--0.0010.0010%0.000+154%0.001+68%0.001+78%
Usd Eps--0.1190.1190%0.055+117%0.052+127%0.033+257%
Usd Free Cash Flow--2254380.0002254380.0000%8982180.000-75%1878585.600+20%1070312.000+111%
Usd Free Cash Flow Per Share--0.0230.0230%0.093-75%0.018+28%0.010+124%
Usd Free Cash Flow To Equity Per Share--0.0160.0160%-0.005+130%0.003+379%0.002+609%
Usd Market Cap338700594.000+15%289553862.468289553862.4680%132969089.916+118%129900596.828+123%85274607.971+240%
Usd Price Per Share4.352+31%2.9872.9870%1.372+118%1.427+109%0.961+211%
Usd Profit--11500812.00011500812.0000%5307792.000+117%4832287.200+138%3014828.000+281%
Usd Revenue--93498672.00093498672.0000%58523844.000+60%54818760.000+71%40286589.333+132%
Usd Total Gains Per Share--0.1200.1200%0.096+24%0.056+114%0.038+218%
 EOD+4 -4MRQTTM+0 -0YOY+26 -85Y+30 -510Y+30 -5

3.2. Fundamental Score

Let's check the fundamental score of Gufic Biosciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.683
Price to Book Ratio (EOD)Between0-113.064
Net Profit Margin (MRQ)Greater than00.123
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.032
Current Ratio (MRQ)Greater than11.715
Debt to Asset Ratio (MRQ)Less than10.484
Debt to Equity Ratio (MRQ)Less than10.937
Return on Equity (MRQ)Greater than0.150.356
Return on Assets (MRQ)Greater than0.050.184
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.283
Ma 20Greater thanMa 50358.723
Ma 50Greater thanMa 100340.125
Ma 100Greater thanMa 200323.649
OpenGreater thanClose377.400
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,214,017
Total Liabilities2,522,837
Total Stockholder Equity2,691,180
 As reported
Total Liabilities 2,522,837
Total Stockholder Equity+ 2,691,180
Total Assets = 5,214,017

Assets

Total Assets5,214,017
Total Current Assets3,207,540
Long-term Assets0
Total Current Assets
Short-term Investments 148,664
Net Receivables 1,515,529
Inventory 1,155,669
Other Current Assets 1,008
Total Current Assets  (as reported)3,207,540
Total Current Assets  (calculated)2,820,870
+/- 386,670
Long-term Assets
Property Plant Equipment 1,554,310
Intangible Assets 6,102
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,560,412
+/- 1,560,412

Liabilities & Shareholders' Equity

Total Current Liabilities1,869,822
Long-term Liabilities0
Total Stockholder Equity2,691,180
Total Current Liabilities
Short-term Debt 65,992
Total Current Liabilities  (as reported)1,869,822
Total Current Liabilities  (calculated)65,992
+/- 1,803,830
Long-term Liabilities
Long term Debt Total 477,261
Capital Lease Obligations Min Short Term Debt-65,992
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)411,269
+/- 411,269
Total Stockholder Equity
Common Stock96,945
Retained Earnings 2,594,235
Total Stockholder Equity (as reported)2,691,180
Total Stockholder Equity (calculated)2,691,180
+/-0
Other
Cash And Equivalents116,080
Cash and Short Term Investments 264,744
Common Stock Shares Outstanding 96,945
Liabilities and Stockholders Equity 5,214,017
Net Working Capital 1,337,718



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,111,458
1,272,879
1,515,982
1,784,631
2,380,322
2,795,397
3,562,407
3,920,610
5,214,017
5,214,0173,920,6103,562,4072,795,3972,380,3221,784,6311,515,9821,272,8791,111,458
   > Total Current Assets 
693,044
914,790
1,189,724
1,432,465
1,982,045
2,325,135
2,634,806
2,605,828
3,207,540
3,207,5402,605,8282,634,8062,325,1351,982,0451,432,4651,189,724914,790693,044
       Cash And Cash Equivalents 
25,415
62,065
42,824
28,727
36,712
36,614
41,839
62,014
0
062,01441,83936,61436,71228,72742,82462,06525,415
       Short-term Investments 
0
0
0
0
37,154
38,901
120,860
69,282
148,664
148,66469,282120,86038,90137,1540000
       Net Receivables 
395,108
473,061
556,895
521,213
808,004
1,031,804
1,012,394
1,245,007
1,515,529
1,515,5291,245,0071,012,3941,031,804808,004521,213556,895473,061395,108
       Inventory 
261,154
368,014
502,631
630,163
942,010
942,846
1,091,977
944,046
1,155,669
1,155,669944,0461,091,977942,846942,010630,163502,631368,014261,154
       Other Current Assets 
10,214
9,484
67,793
224,413
501
6,088
29,681
1,559
1,008
1,0081,55929,6816,088501224,41367,7939,48410,214
   > Long-term Assets 
0
0
0
336,579
390,374
470,262
927,601
0
0
00927,601470,262390,374336,579000
       Property Plant Equipment 
301,862
250,751
221,254
219,901
244,355
337,080
716,963
1,129,253
1,554,310
1,554,3101,129,253716,963337,080244,355219,901221,254250,751301,862
       Goodwill 
0
0
0
0
280
224
210
0
0
002102242800000
       Long Term Investments 
93
93
93
93
0
0
0
0
0
0000093939393
       Intangible Assets 
425
319
213
108
4,373
3,440
5,360
4,451
6,102
6,1024,4515,3603,4404,373108213319425
       Long-term Assets Other 
0
0
0
33,312
16,530
378
377
0
0
0037737816,53033,312000
> Total Liabilities 
849,371
1,001,879
1,228,241
1,411,358
1,838,965
2,041,918
2,603,868
2,186,245
2,522,837
2,522,8372,186,2452,603,8682,041,9181,838,9651,411,3581,228,2411,001,879849,371
   > Total Current Liabilities 
603,103
836,095
1,103,117
1,281,771
1,685,493
1,863,433
2,245,672
1,636,624
1,869,822
1,869,8221,636,6242,245,6721,863,4331,685,4931,281,7711,103,117836,095603,103
       Short-term Debt 
334,040
328,187
322,820
469,672
691,679
846,900
894,327
163,243
65,992
65,992163,243894,327846,900691,679469,672322,820328,187334,040
       Short Long Term Debt 
334,040
328,187
427,572
568,065
713,054
864,363
928,069
0
0
00928,069864,363713,054568,065427,572328,187334,040
       Accounts payable 
317,963
495,333
526,224
397,371
759,794
778,051
1,086,228
0
0
001,086,228778,051759,794397,371526,224495,333317,963
       Other Current Liabilities 
57,210
68,628
84,409
139,966
72,456
95,566
95,019
0
0
0095,01995,56672,456139,96684,40968,62857,210
   > Long-term Liabilities 
0
0
0
176,385
153,009
178,485
358,195
0
0
00358,195178,485153,009176,385000
       Long term Debt Total 
0
0
74,579
66,232
83,192
113,117
179,235
382,489
477,261
477,261382,489179,235113,11783,19266,23274,57900
       Capital Lease Obligations 
0
0
0
1,705
1,078
379
96,329
0
0
0096,3293791,0781,705000
       Long-term Liabilities Other 
0
0
0
80,493
0
1
-2
0
0
00-21080,493000
> Total Stockholder Equity
262,087
271,000
287,741
373,273
541,357
753,479
958,539
1,734,365
2,691,180
2,691,1801,734,365958,539753,479541,357373,273287,741271,000262,087
   Common Stock
77,350
77,350
77,350
77,350
77,830
77,830
77,830
96,945
96,945
96,94596,94577,83077,83077,83077,35077,35077,35077,350
   Retained Earnings 
183,487
192,400
210,391
295,923
463,527
675,649
880,709
1,637,420
2,594,235
2,594,2351,637,420880,709675,649463,527295,923210,391192,400183,487
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
1,250
1,250
1,250
1,250
1,250
714
-19,083
0
0
00-19,0837141,2501,2501,2501,2501,250



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue6,906,208
Cost of Revenue-3,642,668
Gross Profit3,263,5403,263,540
 
Operating Income (+$)
Gross Profit3,263,540
Operating Expense--
Operating Income1,153,3093,263,540
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,789,874
Selling And Marketing Expenses-
Operating Expense-1,789,874
 
Net Interest Income (+$)
Interest Income81,838
Interest Expense--
Other Finance Cost-81,838
Net Interest Income-
 
Pretax Income (+$)
Operating Income1,153,309
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,067,2091,153,309
EBIT - interestExpense = 0
797,048
797,048
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-1,067,209
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,067,209
Tax Provision-270,161
Net Income From Continuing Ops-797,048
Net Income797,048
Net Income Applicable To Common Shares797,048
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Gufic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gufic. The general trend of Gufic is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gufic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gufic Biosciences Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 379.35 < 387.00.

The bearish price targets are: 349.00 > 343.95 > 294.85.

Tweet this
Gufic Biosciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gufic Biosciences Limited. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gufic Biosciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gufic Biosciences Limited. The current macd is 6.74112971.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gufic price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gufic. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gufic price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Gufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartGufic Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gufic Biosciences Limited. The current adx is 19.41.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gufic shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Gufic Biosciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gufic Biosciences Limited. The current sar is 379.84.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Gufic Biosciences Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gufic Biosciences Limited. The current rsi is 57.28. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Gufic Biosciences Limited Daily Relative Strength Index (RSI) ChartGufic Biosciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gufic Biosciences Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gufic price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Gufic Biosciences Limited Daily Stochastic Oscillator ChartGufic Biosciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gufic Biosciences Limited. The current cci is 109.40.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Gufic Biosciences Limited Daily Commodity Channel Index (CCI) ChartGufic Biosciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gufic Biosciences Limited. The current cmo is 14.00.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Gufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) ChartGufic Biosciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gufic Biosciences Limited. The current willr is -47.17514124.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Gufic is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Gufic Biosciences Limited Daily Williams %R ChartGufic Biosciences Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Gufic Biosciences Limited.

Gufic Biosciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gufic Biosciences Limited. The current atr is 15.68.

Gufic Biosciences Limited Daily Average True Range (ATR) ChartGufic Biosciences Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gufic Biosciences Limited. The current obv is 328,537.

Gufic Biosciences Limited Daily On-Balance Volume (OBV) ChartGufic Biosciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gufic Biosciences Limited. The current mfi is 56.12.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Gufic Biosciences Limited Daily Money Flow Index (MFI) ChartGufic Biosciences Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gufic Biosciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Gufic Biosciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gufic Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.283
Ma 20Greater thanMa 50358.723
Ma 50Greater thanMa 100340.125
Ma 100Greater thanMa 200323.649
OpenGreater thanClose377.400
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gufic with someone you think should read this too:
  • Are you bullish or bearish on Gufic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gufic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gufic Biosciences Limited

I send you an email if I find something interesting about Gufic Biosciences Limited.


Comments

How you think about this?

Leave a comment
3rd party ad coffee SUPPORTERis ad-free.

Stay informed about Gufic Biosciences Limited.

Receive notifications about Gufic Biosciences Limited in your mailbox!